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(b) the two Ca2+/calmodulin-dependent protein kinases CaMKKα and 
CaMKKβ,7 and (c) the transforming growth factor TGF-β-activated 
kinase-1 and TAK1.8 In addition, recently, it has been demonstrated 
that AMPK is a redox-sensitive kinase where activity is negatively 
regulated by oxidation of Cys130 and Cys174 and that reduction of 
both Cys by thioredoxin1 is essential for activation of AMPK during 
energy stress by starvation.9
AMPK is deregulated in humans with metabolic syndrome, type 2 
diabetes, and other reverse metabolic abnormalities, as well as in cancer2 
and oxidative-stress-related diseases such as myocardial ischemia.2,10 
Substantial evidence shows that AMPK activation can improve insulin 
sensitivity and metabolic health and exerts anticancer properties.11–15 
Pharmacological agents such as metformin that are known to activate 
AMPK are currently used to treat type 2 diabetes11,13–15 and possess 
anticancer properties.13–15 Therefore, AMPK is considered a promising 
target for drugs aimed to fight cancer and the increasing epidemic of 
metabolic disorders.12 Moreover, AMPK also becomes activated by 
INTRODUCTION
The AMP-activated protein kinase (AMPK) acts as a sensor of cellular 
energy status that, when activated by different stimuli, maintains 
energy homeostasis at both cellular and whole-body levels.1,2 This 
kinase is an evolutionary conserved heterotrimeric protein with 
activity serine/threonine kinase that structurally contains a catalytic 
α subunit and two regulatory subunits, β and γ. AMPK responds to a 
rise in AMP levels (which reflects low cell energy state) by switching on 
ATP-generating pathways and switching off ATP-consuming anabolic 
processes.1,3 The overall metabolic consequence of AMPK activation 
is the maintenance of energy levels under ATP-limiting conditions. 
As a result of the high sensitivity of AMPK toward AMP, any rise 
in the ratio AMP/ATP due to a fall in cell energy state stimulates 
AMPK activity4 by both allosteric activation and enhancing net 
phosphorylation.5 To date, the following kinases can phosphorylate 
AMPK at Thr172 in somatic cells: (a) the tumor suppressor responsible 
for the inherited cancer disorder Peutz–Jeghers syndrome, LKB1,6 
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Analysis System (ISAS) in the presence or absence of the AMPK inhibitor compound C (CC). AMPK is localized along the human 
spermatozoa, at the entire acrosome, midpiece and tail with variable intensity, whereas its active form, phospho‑Thr172‑AMPK, 
shows a prominent staining at the acrosome and sperm tail with a weaker staining in the midpiece and the postacrosomal region. 
Interestingly, spermatozoa bearing an excess residual cytoplasm show strong AMPK staining in this subcellular compartment. Both 
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different types of cell and metabolic stress3,16,17 and, therefore, this 
kinase regulates several cell processes outside metabolism.1,3
All AMPK-related researches had been studied in somatic 
cells until 2008, where it was reported that a short splice variant of 
the AMPK upstream kinase, called LKB1s, plays a crucial role in 
spermiogenesis, motility, and fertility in mice.18 Moreover, the deletion 
of two testis-specific kinases related to AMPK, TSSK1 and 2, caused 
male infertility in chimera mice.19 In 2012, our group reported for 
the first time that AMPK protein is highly expressed in mammalian 
spermatozoa.20,21 Active AMPK plays a relevant role in the regulation 
of key functional boar sperm processes,22 such as motility,20,22 
mitochondrial membrane potential, lipid organization and fluidity of 
sperm plasma membrane and the integrity of acrosome membrane at 
physiological temperature21 and also during boar semen preservation 
at 17°C.23  Supporting our finding of an essential role of AMPK in 
the sperm function, Tartarin et  al.24 demonstrated that α1AMPK 
knockout mice (KO) showed decreased fertility, alteration in sperm 
morphology, diminished mitochondrial membrane potential, lower 
basal oxygen consumption, and decreased sperm motility. Regarding 
intracellular pathways controlling AMPK in porcine spermatozoa, 
we have recently demonstrated that AMPK is activated by Ca2+ and 
HCO3
− through the activation of the soluble adenylyl cyclase that in 
turn produces an increase in intracellular cAMP, which subsequently 
activates PKA.21,25 Other kinases involved in AMPK signaling pathway 
in boar spermatozoa include CaMKKα/β and PKC.21,25
Spermatozoa are challenged to survive and adapt to extracellular 
extreme conditions including metabolic or environmental stress that 
might physiologically occur during their transit through the female 
reproductive tract. Based on our hypothesis, AMPK, acting as an 
energy- redox- and stress-sensor molecule, would regulate the most 
relevant cellular functions of human sperm required for successful 
oocyte fertilization.26 Therefore, the aims of this work are (a) to identify 
and locate the AMPK protein in human spermatozoa,  (b) to study 
AMPK activity status in fresh human sperm populations (high and 
low motility), and (c) to investigate whether AMPK plays a role in the 
regulation of human sperm motility from healthy men.
MATERIALS AND METHODS
Ethical approval
The study was conducted in accordance with ethical guidelines, and 
informed and written consent was obtained from all individuals 
included in the study. Human semen was obtained from healthy 
donors, prepared and evaluated in line with the recommendations and 
current values of the World Health Organization (WHO).27 Protocols 
were approved by the University of Extremadura Ethical Committee.
Human semen samples
Semen samples from 14 healthy donors were obtained by masturbation 
into a sterile plastic container after 2–3  days of sexual abstinence 
and analyzed following WHO recommendation.27 After complete 
liquefaction, samples were examined and processed. The semen 
parameters  (total fluid volume, sperm concentration, motility, and 
morphology) of all the samples fell within the WHO normality 
criteria. Before those experiments intended for Western blot analysis 
or sperm motility, two different fractions of spermatozoa (high and 
low motility) were separated by a silane-silica based 40%–80% density 
gradient medium used in artificial reproduction techniques for the 
separation and purification of highly motile human spermatozoa. 
Briefly, aliquots of semen (1 ml) from 5 donors (n = 5) were layered 
over the upper layer of the density gradient and centrifuged at room 
temperature for 20 min at 300 g. Two sperm fractions were collected: 
high- and low-motility fractions that were suspended at the required 
concentration in phosphate buffered saline (PBS) for AMPK protein 
analysis or in sperm washing medium  (SWM; Irvine Scientific, 
Santa Ana, CA, USA), that includes sodium chloride, potassium 
chloride, magnesium sulfate anhydrous, potassium phosphate 
monobasic, calcium chloride anhydrous, sodium bicarbonate, 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), glucose, 
sodium pyruvate, sodium lactate, phenol red, and human serum 
albumin (HSA) for motility analysis. Quality parameters such as sperm 
concentration and motility parameters were evaluated in each fraction.
Indirect immunofluorescence
Aliquots of 40 µ l  of sperm samples were f ixed with 4% 
paraformaldehyde  (50  ×  106 sperm per ml), washed with PBS, 
permeabilized with Triton X-100 (0.25%, v/v), washed again and blocked 
with bovine serum albumin (BSA) (3%, w/v) for 30 min as described 
before.21 Incubations with two primary antibodies against AMPK: 
anti-AMPKα1/2 rabbit polyclonal antibody raised against amino acids 
251-550 mapping at the C-terminus of AMPKα1 of human origin (Santa 
Cruz Technology, Santa Cruz, CA, USA) or anti-AMPKα1/2 synthetic 
peptide conjugated to keyhole limpet hemocyanin (KLH) from around 
amino acids 181-185/170-174 (LRTSC) of human AMPKα1 + AMPKα2 
(Abcam, Cambridge, UK; 1:25, v/v) were carried out overnight at 4 °C. 
Incubation with primary antibody P-Thr172-AMPK (Santa Cruz 
Technology, Santa Cruz, CA, USA; 1:100, v/v) was carried out for 2 h at 
room temperature. After washing, samples were incubated with Alexa 
Fluor 488 goat anti-rabbit IgG (Life Technologies Ltd., Grand Island, NY, 
USA; 1:200, v/v) for 60 min at room temperature. As negative controls, 
samples incubated exclusively with a secondary antibody and without a 
primary antibody were run in parallel. Furthermore, routine negative 
controls were performed using the specific blocking peptide for the 
P-Thr172-AMPK antibody (Santa Cruz Biotechnology, Santa Cruz, CA, 
USA). Coverslips were washed and mounted on slides containing 5 µl 
of nuclear stain 4,6-diamidino-2-phenylindole hydrochloride (DAPI, 
125 µg l−1; Invitrogen Molecular Probes, Grand Island, NY, USA) with 
an antifading mounting solution. The coverslips were finally sealed and 
stored until microscope observation. Fluorescent images were obtained 
using both a fluorescence Olympus I × 51 microscope equipped with a 
DP70 camera (Olympus, Tokyo, Japan) and a confocal laser scanning 
fluorescence microscope (Fluoview 1000, Olympus, Tokyo, Japan) with 
a 60X NA 1.45 oil immersion objective.
Western blot analysis
Human sperm lysates were prepared from high-  and low-motility 
sperm fractions  (concentration range of 80  ×  106–100  ×  106 
sperms per ml) as previously described.20 Human sperm proteins 
were analyzed by Western blot as reported22,24 using the following 
primary antibodies: anti-AMPKα1/2 rabbit polyclonal antibody 
raised against amino acids 251–550 mapping at the C-terminus of 
AMPKα1 of human origin (Santa Cruz Technology; 1:1000, v/v) and 
anti-phospho-Thr172-AMPKα1/2 rabbit polyclonal antibody raised 
against a short amino acid sequence containing Thr172 phosphorylated 
AMPKα2 of human origin (Santa Cruz Technology, Santa Cruz, CA, 
USA; 1:1000, v/v). As a loading control, we later blotted each membrane 
with an anti-α-tubulin (SIGMA, St. Louis, MO, USA; 1:10000, v/v) 
monoclonal antibody.
Human spermatozoa motility analysis
High- and low-motility human sperm fractions from six individuals with 
normal sperm parameters according to WHO were incubated (20 × 106 
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sperms per ml) in SWM with an equal volume of the AMPK inhibitor 
compound C (CC) (SIGMA, St. Louis, MO, USA; 30 µmol l−1) or the 
solvent Dimethyl sulfoxide (DMSO) (0.024%) for different times (0 min, 
30 min, 60 min, 120 min, 180 min and 240 min and 20 h) at 37°C in a 
CO2 incubator. The following motility parameters were then evaluated 
using the ISAS system (PROISER, Paterna, Valencia, Spain): percent 
of motile and progressive spermatozoa, curvilinear velocity  (VCL), 
straight-line velocity (VSL), average path velocity (VAP), amplitude 
of lateral head movement (ALH), linearity (LIN), and beat cross of 
flagellum frequency (BCF). The settings of the system analyzer were 
frame rate, 60 Hz; frame acquired, 25; straightness threshold, 80%; 
and temperature, 37°C. The total number of sperm evaluated in each 
semen sample was at least 300.
Analysis of spermatozoa viability by flow cytometry
As described previously,20,23 fluorescent staining using the Live/Dead 
sperm viability kit (Thermo Fisher Scientific, Grand Island, NY, USA) 
was performed to measure spermatozoa viability. Briefly, 200 µl of 
semen sample (20 × 106 cells per ml) were incubated in SWM for 20 min 
at room temperature in darkness with 2.5 µl of SYBR® 14 dye (2 µmol l−1) 
and 5 µl of propidium iodide (PI) (480 µmol l−1), followed by an analysis 
in the flow cytometer  (ACEA NovoCyte™; ACEA Biosciences, Inc., 
San Diego, CA, USA) using ACEA NovoExpress™ software. The 
fluorescence values of SYBR-14 were collected in the laser-excited 
fluorescence channel  (BL) 1 using a 525  nm pass filter whereas PI 
fluorescence was collected in the BL3 channel using a 620 nm bad pass 
filter. The results of viable spermatozoa were expressed as the average 
of the percentage of SYBR-14+ and PI− labeled cells ± standard error 
of the mean.
Statistical analysis
The mean and standard error of the mean in experiments performed 
with CC were calculated for descriptive statistics. The effects of 
treatment  (untreated and CC) and time  (0  min, 30  min, 60  min, 
120 min, 180 min and 240 min and 20 h) on several seminal motility 
characteristics were analyzed statistically using a General Linear 
Model; a mixed-effects model (with samples as random effects and 
treatment and time as fixed effects) was applied to the experimental 
design. Scheffe test was used to perform post hoc tests. All analyses were 
performed using SPSS version 15.0 (SPSS Inc., Chicago, IL, USA). The 
level of significance was set at P < 0.05.
RESULTS
Identification and intracellular localization of AMPK protein in 
human spermatozoa
The subcellular localization of AMPK protein in human sperm was 
investigated by indirect immunofluorescence using two different 
anti-AMPK antibodies that recognize distinct amino acid sequences 
within the catalytic α subunit (1 and 2 isoforms) of the human origin 
protein (Abcam: 181–185/170–174 of AMPK α1/2 and Santa Cruz: 
251–550 at the C-terminus). Results show that AMPK protein is 
highly expressed in fresh human ejaculated sperm and is localized 
along the spermatozoa, at the entire acrosome, at the midpiece, 
and along the tail of the flagellum with variable and/or punctate 
intensity  (Figure 1a–1i). A  more detailed analysis was performed 
by studying a single spermatozoon and visualizing intensity patterns 
obtained by serial images with different cell depths (every 5 µm) in 
the confocal microscopy (Figure 1j–1o). This experiment shows that 
the intensity of the signal derived from sperm AMPK varies with 
the depth at which the confocal microscope renders spermatozoon 
visualization and also reflects that a single visualization of an image 
showing a particular AMPK intensity in sperm cells should be carefully 
taken, especially when a lack of signal is observed.
Particular attention should be paid to those human spermatozoa 
that bear an excess residual cytoplasm (ERC),28 which presents strong 
AMPK staining visualized by three different patterns of AMPK 
localization along their midpiece (Supplementary Figure 1). In any 
case, AMPK clearly localizes at ERC with higher intensity than other 
regions of spermatozoa.
Identification and intracellular localization of the active form of 
AMPK (phospho‑Thr172‑AMPK) in human spermatozoa
The subcellular localization of the active form of AMPK in human sperm 
was approached by the evaluation of the phospho-Thr172-AMPK signal 
derived from the antibody raised against a short amino acid sequence 
containing Thr172 phosphorylated AMPKα2 of human origin. As 
shown in Figure  2a–2f, phospho-Thr172-AMPK staining analysis 
reveals that active AMPK is located along human spermatozoa, showing 
a prominent staining at the most apical part of the acrosome region 
and at the sperm tail, where occasional punctate staining is observed. 
Interestingly, results show weaker phospho-AMPK staining in two 
particular spermatozoa regions: the postacrosomal region of the head 
where the DAPI-stained nuclei are found and in the midpiece region 
of the tail where the sperm mitochondria are located. A more detailed 
analysis of active AMPK localization was performed by studying a 
single spermatozoon and visualizing the intensity patterns obtained 
by serial images with different cell depths (every 5 µm) in the confocal 
microscope  (Figure 2m–2r). These images show that active AMPK 
staining clearly varies with the depth at which the confocal microscope 
renders spermatozoon visualization and confirm that the enzymatically 
active form of AMPK protein is expressed in the whole human 
spermatozoa with two regions where levels are weaker: postacrosomal 
and midpiece regions. Different negative controls of this experiment were 
performed (Figure 2g–2l). A representative staining image of sperm 
preincubated with phospho-Thr172-AMPK-specific blocking peptide 
is shown on the left side (Figure 2g–2i). Moreover, a representative 
staining image of sperm incubated only with the secondary antibody 
and where the primary antibody was omitted is shown in the right 
side of Figure 2j–2l. Interestingly, ERC-bearing spermatozoa show a 
punctate staining of phospho-Thr172-AMPK at ERC, although with 
lower intensity than at other phospho-AMPK enriched-regions of sperm, 
such as tail or acrosome (Supplementary Figure 2).
Identification of AMPK protein and its active form, phospho‑Thr172 
AMPK, in human spermatozoa by Western blotting
Evaluations of the AMPK protein and its active form (phosphorylated) 
in fresh ejaculated human sperm were further approached by Western 
blot. As shown in Figure 3a, in some donors, a single cross-reactive 
band is detected in spermatozoa lysates from human ejaculates 
using a specific antibody against AMPKα1/2. A  negative control 
was performed omitting the primary antibody and blotting with the 
secondary antibody only (data not shown). No band is detected with 
the secondary antibody, which confirms that the band visualized is 
due to the AMPKα1/2 antibody. Interestingly, in other donors, the 
second band with slightly lower molecular weight is detected with 
similar  (#0016) or even higher intensity  (#0015) than the initial 
cross-reacted band  (Figure  3b), which corresponds to AMPK α1 
and α2, as the antibody used effectively recognizes both AMPKα1/2 
isoforms. AMPK content in human sperm shows great individual 
variations (Figure 3).
AMPK phosphorylation was analyzed in the same fresh ejaculates 
as an assessment of its enzymatic activity state in human sperm. 
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The active form of AMPK is detected in human sperm as a single 
cross-reactive band with the expected molecular weight (Figure 4a). 
The intensity of the cross-reactive band indicates that content of 
phospho-Thr172-AMPK in human sperm shows important individual 
variations. We also investigated the activity state of AMPK in the low and 
high motility sperm fraction of each donor; separated by a 40%–80% 
density gradient used in assisted reproduction techniques (ART) for 
isolation of highly motile human sperm (Figure 4b). For each donor, 
active AMPK is clearly predominant in the high motility sperm fraction 
where it is present with higher intensity than in the low motility sperm 
fraction (compare donor #0004 and #0014; Figure 4c).
Effect of the AMPK inhibition by compound C on human sperm 
motility
To investigate the role of AMPK in human sperm motility, we used 
an AMPK inhibitor, CC, which clearly inhibits AMPK activity in 
boar sperm20 without affecting sperm viability. Human sperm was 
incubated with CC (30 µmol l−1) for different times (0–20 h) at the 
physiological temperature of 37°C and sperm motility was evaluated. 
Short-term CC treatment did not modify human sperm motility 
Figure 2: Subcellular localization of the active form of AMPK 
(phospho‑Thr172‑AMPK) in human spermatozoa. Phospho‑Thr172‑AMPK 
was detected in spermatozoa with the secondary antibody Alexa Fluor 
488 goat anti‑rabbit immunoglobulin G. Sperm were stained in green with 
anti‑phospho‑Thr172‑AMPK antibody while sperm nuclei were stained 
with DAPI (blue). Images from (a–f): Phospho‑Thr172‑AMPK staining was 
visualized using epifluorescence (a–c), or confocal microscopy (d–f). Left 
panels (a and d) show bright field images, central panels (b and e) show 
IgG‑Alexa 488 images and right panels (c and f) represent DAPI images. 
Images from (g–l) show negative controls: (g–i) Spermatozoa were preincubated 
with phospho‑Thr172‑AMPK specific blocking peptide (5X); (j–l) spermatozoa 
were incubated only with the secondary antibody Alexa Fluor 488 and primary 
antibody was omitted. Serial images (m–r) of confocal microscopy were obtained 
from a unique spermatozoon using different focus depths (5 µm thickness) 
and showing the overlapping IgG‑Alexa 488 (green) and DAPI (blue) staining 
after incubation with the anti‑phospho‑Thr172‑AMPK antibody. Images are 

















Figure 1: Subcellular localization of AMPK protein in human spermatozoa. 
AMPK was detected in human sperm using epifluorescence (a–c) or confocal 
(d–i) microscopy. Two different antibodies were used: from (a–f) anti‑AMPK 
antibody against amino acids 181–185 and 170–174 of AMPKα 
subunit (Abcam) where (a) and (d) are bright field images, (b) and 
(e) are IgG‑Alexa 488 images, and (c) and (f) are DAPI stained images; 
from (g–i) anti‑AMPK antibody against amino acids 251–550 at the 
C‑terminus of AMPKα subunit (Santa Cruz Technology) where (g) is bright 
field image, (h) is IgG‑Alexa 488 image and (i) is DAPI stained image. Serial 
of confocal microscopy images (j–o) obtained from a unique spermatozoon 
using different focus depth (5 µm thickness) are shown by overlapping 
IgG‑Alexa 488 (green) and DAPI (blue) staining after incubation with 
anti‑AMPK antibody (Santa Cruz Technology). Images are representative of 
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parameters such as percent of motile sperm, velocities VCL, VSL, 
VAP  (Supplementary Table  1) or progressivity, ALH, LIN, and 
BCF (Supplementary Table 2). However, 20 h of treatment of human 
sperm with CC leads to a statistically significant reduction (by 65%) 
in the percent of motile sperm (Figure 5a) falling from 39% of total 
motile sperm in CC absence to 13% in CC presence. Accompanying 
this fall in the number of motile sperm, CC treatment for 20 h causes 
a clear and statistically significant reduction  (about 50%) in sperm 
velocities: VCL from 91 µm s−1 in the absence of CC to 44 µm s−1 
with CC (Figure 5b), VAP from 64 µm s−1 in CC absence to 27 µm 
s−1 with CC (Figure 5c) and VSL from 54 µm s−1 in CC absence to 26 
µm s−1 in presence of CC (Figure 5d). Among the reduced number of 
motile spermatozoa, AMPK inhibition for 20 h causes a statistically 
significant decrease (by 67%) in the percentage of those sperm with a 
progressive motility (Figure 6a) from 36% in CC absence to 12% in 
CC presence. AMPK inhibition for 20 h in human sperm also leads to 
a statistically significant decrease of coefficients ALH (45% reduction, 
Figure 6b), LIN (60% reduction, Figure 6c), and BCF (56% reduction, 
Figure 6d). These negative effects of the AMPK inhibitor in human 
spermatozoa motility occur without affecting sperm viability as shown 
in Supplementary Table 3.
DISCUSSION
A fine regulation of cell metabolism is achieved in sperm by dynamic 
mechanisms that effectively manage their adaptation to environmental 
changes that occur during their transit through the female reproductive 
tract. Thus, control of energy levels during changing extracellular 
conditions leading to oocyte fertilization is of essential relevance in 
the understanding of sperm function. Among the mechanisms that 
sense cell energy and redox status is AMPK that controls metabolic 
pathways by its activity state. In sperm, the AMPK protein was first 
identified in boar by our group in 2012.20 Since then, AMPK has 
been identified in other animal species such as mice,24 stallion29 
and chicken.30 To date, there are no studies about the presence or 
function of AMPK in human spermatozoa. This work demonstrates 
for the first time that AMPK protein is present in the whole human 
spermatozoa. Moreover, AMPK mainly localizes at the sperm head, 
particularly at the acrosome, the midpiece and along the sperm tail. 
Apart from AMPK staining at the human sperm tail being stronger 
than in boar,21 there are no relevant differences in sperm localization 
of AMPK between these two mammalian species. When we focus 
on the localization of the active form of AMPK, it becomes evident 
that there is a clear difference in its localization between human and 
boar spermatozoa. While both mammalian species express relative 
amounts of active AMPK at the acrosome, they differ at the midpiece, 
as boar spermatozoa express marked amounts of active AMPK in this 
region and also in the subequatorial segment.21 This difference in the 
localization of active AMPK, a major regulator of energy metabolism, 
in the midpiece region between mammalian spermatozoa species is 
an interesting finding that might suggest that the localization of active 
AMPK in sperm of mammalian species is dependent on their energy 
producing intracellular compartments. In fact, the precise balance 
between glycolysis and mitochondrial oxidative pathways is different 
among species. Then, mammalian species that obtain metabolic energy 
for sperm mainly from the glycolysis, as it appears in humans,31 would 
express higher amount of active AMPK in the limited cytosol, restricted 
Figure 3: Identification of AMPK protein in human sperm by Western 
blotting. (a) Human sperm proteins (10 µg) from different donors were 
analyzed by Western blot using anti‑AMPKα1/2 as the primary antibody. 
(b) Different patterns of AMPK cross‑reacted bands in several donors of human 
sperm. Arrows indicate cross‑reactive bands of AMPK protein recognized by 
the antibody. Molecular weight markers are indicated in KDa. Loading control 
was performed for each experiment in the same membranes using the anti‑α 
tubulin antibody and is shown on the lower panels. Each experiment was 
performed seven times and representative films are shown.
ba
Figure 4: Identification of phospho‑Thr172‑AMPK (active) in human spermatozoa, which is predominant in the high motility sperm population. (a) Proteins 
(10 µg) from same human sperm lysates used in Figure 3 were analyzed by Western blot using anti‑phospho‑Thr172‑AMPKα as the primary antibody. Arrows 
indicate the cross‑reactive band of phosphorylated AMPK protein recognized by the antibody. Molecular weight markers are indicated in KDa. Loading 
control was performed for each experiment in the same membrane using the anti‑α tubulin antibody and is shown in the lower panels. This experiment was 
performed seven times and a representative film is shown. (b) Each human ejaculate was fractioned by a 40%–80% density gradient in high and low motility 
sperm populations and AMPK phosphorylation was analyzed. This experiment was performed five times and a representative film (with n = 2) is shown. 
(c) Densitometric quantitation of the phospho‑Thr172‑AMPKα bands obtained in each fraction (high and low). Values obtained for phospho‑Thr172‑AMPK 
bands were normalized with values of α‑tubulin.
cba
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to the most apical region of the head, and to the tail. Boar spermatozoa 
may use both energy-obtaining pathways and therefore also express 
important levels of active AMPK in the midpiece. In stallions, active 
AMPK localization was limited to discreet points on the anterior 
region (sub-equatorial band) and principal piece of tail,29 consistent 
with the stallion’s biggest reliance on oxidative phosphorylation for 
sperm ATP production. To date, there are no other works studying the 
localization of AMPK in sperm from other species to confirm the idea 
that the role and intracellular localization of AMPK in sperm could 
potentially be driven by metabolism evolution.
A special relevance merits the fact that AMPK is also localized in 
human sperm that show an ERC, which has been distinguished from 
cytoplasmic droplet by size and implications,32 specially regarding 
male infertility as a pathophysiological consequence.28 The stronger 
AMPK signal detected in ERC-bearing human spermatozoa compared 
with other regions of those spermatozoa suggests that AMPK might 
be important during spermiogenesis or cytoplasmic extrusion as 
ERC is caused by an arrest in either processes.28 Since ERC-bearing 
spermatozoa are unable to complete maturation, they have been 
considered as “dysmature” sperm.28 ERC has several pathological 
implications for spermatozoa, mainly due to elevated levels of key 
enzymes found within the cytoplasm itself: glucose 6-phosphate 
dehydrogenase (G6PDH) that generates greater nicotinamide adenine 
dinucleotide phosphate (NADPH) production, sperm-specific creatine 
kinase  (CK-M) and lactate dehydrogenase  (LDH) that generate 
an excess of O2
−  production, or superoxide dismutase  (SOD) that 
produces an excess of H2O2.
28 Among the negative effects associated 
with ERC are peroxidative damage to sperm membrane, DNA 
damage, mitochondrial dysfunction, and subsequently impaired 
sperm function (motility, capacitation, or fertilization). Therefore, the 
localization of important AMPK levels at the ERC compared with other 
regions of the human sperm raises several hypotheses: (a) a possible 
involvement of AMPK during human spermiogenesis; (b) a possible 
AMPK activation in response to the potent oxidative stress induced 
in ERC, which is supported by the fact that sperm AMPK becomes 
rapid and strongly activated by different stresses in other mammalian 
species.22 Moreover, sperm AMPK activity might be regulated by ERC 
redox state as it has recently been demonstrated in somatic cells that 
AMPK is a redox-sensitive kinase, whose activity is controlled by cell 
redox state during energy stress.9 In any case, we think that the finding 
of relative high levels of AMPK localizing at ERC warrants prospective 
studies in human sperm to further clarify its role and its potential 
implications in male infertility.
Western blot reveals two immunoreactive bands with close lower 
molecular weight visualized in human sperm. The AMPKα1/2 antibody 
reacts with two catalytic α isoforms of human origin  (α1 and α2); 
therefore, these two cross-reactive bands found in human sperm are 
likely α1 and α2 isoforms of AMPK, as we have previously described 
Figure 6: Effect of the AMPK inhibition by compound C (CC) for 20 h in human 
sperm motility coefficients. After isolation by density gradient, human sperm 
were incubated at 37°C in the absence (unfilled bars) or presence (filled bars) 
of AMPK inhibitor CC (30 µmol l−1) during 20 h. Following motility coefficients 
were evaluated by the ISAS system: (a) Number of motile spermatozoa 
with progressive motility, expressed as % of total sperm, (b) amplitude of 
lateral sperm head displacement, expressed in µm, (c) linearity expressed 
in % and (d) beat cross frequency, expressed in Hz. This experiment was 
performed at least six times and results express the mean ± standard 
error of the mean. Statistical differences were considered when P < 0.05: 
histograms with different letters (a–c) are statistically different from each 




Figure 5: Effect of the AMPK inhibition by compound C (CC) for 20 h in human 
sperm motility parameters. After isolation by density gradient human sperm 
were incubated at 37°C in the absence (unfilled bars) or presence (filled 
bars) of AMPK inhibitor compound C (CC 30 µmol l−1) during 20 h. 
Following sperm motility parameters were evaluated by the ISAS system: 
(a) Motile spermatozoa, expressed as % of total spermatozoa, (b) curvilinear 
velocity, (c) average velocity and (d) straight‑line velocity expressed as µm s−1. 
This experiment was performed at least six times and results express the 
mean ± standard error of the mean. Statistical differences were considered 
when P < 0.05: histograms with different letters (a–c) are statistically different 
from each other. ISAS: integrated semen analysis system.
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occurs in boar sperm.20 Interestingly, the AMPKα1 and 2 content in 
human sperm show important individual variations. As expected, also 
the active form of AMPK is expressed in human spermatozoa with 
quantitatively marked individual variations.
To study a possible relationship between AMPK and human 
sperm function, we separated human sperm in high and low motility 
populations by a density gradient used in ART for the selection of highly 
motile human sperm. Strong levels of active AMPK are predominant 
in the high motility fraction that includes morphologically normal 
sperm whereas active AMPK levels are clearly lower in the low-quality 
human sperm fraction that contains less motile or immotile sperm. 
This finding suggests a correlation between AMPK activity and human 
sperm motility that was further confirmed using an AMPK inhibitor. 
Keeping in mind its cellular energy-regulating role, it is logical that 
AMPK plays a role in motility, sperm function that is particularly 
dependent on the energy levels. In fact, this study demonstrates that 
the inhibition of AMPK activity in human sperm, for at least 20 h, 
leads to a marked reduction in sperm motility, drastically decreasing 
the number of motile sperm along with a clear reduction in their 
velocities. Under conditions of AMPK inhibition, those remnant 
human sperm that are still motile present a clearly less progressive 
movement together with a less efficient or competent motility. Thus, our 
study demonstrates that AMPK activity in human sperm is necessary to 
maintain proper sperm motility. The fact that a certain (physiological) 
level of AMPK activity is essential to maintain a correct human 
sperm motility adapted to the changing extracellular environment 
is supported by our previous studies in other mammalian species, 
boar20,22 and also by others in α1AMPK knockout mice24 or even in 
avian sperm.30 Moreover, AMPK pathway exerts pleiotropic regulatory 
actions at different functional levels in mammalian sperm,22 playing 
key roles in several processes:  (a) the maintenance of physiological 
mitochondrial membrane potential,21,26 (b) correct lipid organization 
and phosphatydilserine externalization in sperm plasma membrane,21,26 
and  (c) the integrity of acrosome membrane.21,22 We have recently 
established that AMPK activity in boar sperm is regulated upstream 
by different kinases such as PKA, CaMKKα/β, and PKC, as well as 
by essential intracellular messengers for sperm function, Ca2+  and 
cAMP levels.25 One might expect that in addition to motility, human 
AMPK would also be involved in these mentioned sperm functional 
processes, which are essential for the ultimate function of sperm, 
oocyte fertilization, although future research should confirm this idea 
in human species.
CONCLUSION
We propose for the first time that AMPK protein, which is present 
in human sperm, plays an important and necessary regulatory role 
in motility, with subsequent implications for human fertility. In this 
regard, future investigations, along with our current ongoing research, 
will determine what physiological factor (s) trigger the activation of 
AMPK in human sperm and how AMPK activity is modulated by 
intracellular signaling pathways in these male germ cells with the 
ultimate goal of knowing whether the assessment of AMPK in human 
sperm might be relevant for male infertility.
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Supplementary Table 1: Short‑term effect (0–4 h) of the AMPK inhibition by CC in human spermatozoa motility parameters
Time (min) Motile spermatozoa (%) Curvilinear velocity (µm s−1) Average velocity (µm s−1) Linear velocity (µm s−1)
Control CC Control CC Control CC Control CC
0 70.4±4.8 73.6±5.0 137.3±14.7 139.2±15.4 87.0±13.7 88.9±14.2 103.2±14.6 104.7±15.8
30 69.4±5.6 72.2±4.6 112.9±11.4 126.7±15.7 67.7±9.7 73.6±12.1 82.3±10.2 91.2±14.7
60 65.3±6.2 71.4±5.9 100.1±19.0 116.8±10.5 68.9±11.7 67.6±9.6 82.9±12.5 82.5±10.3
120 65.2±5.0 66.8±6.5 87.3±16.4 109.9±10.7 61.7±8.7 58.7±10.0 74.0±9.5 73.9±10.9
180 67.1±4.3 69.9±5.8 95.3±8.2 112.8±10.4 57.7±7.6 60.2±9.2 69.7±8.1 75.8±9.9
240 61.9±8.2 70.2±7.7 89.0±10.0 92.7±24.7 52.9±7.8 60.1±13.3 52.0±14.2 74.6±14.1
Spermatozoa motility parameters were evaluated by the ISAS system. This experiment was performed at least six times and data are presented as mean±s.e.m. ISAS: integrated semen 
analysis system; AMPK: AMP‑activated kinase; CC: compound C; s.e.m.: standard error of the mean
Supplementary Table 2: Short‑term effect (0–4 h) of the AMPK inhibition by CC in human spermatozoa motility coefficients
Time (min) Progressive motility (%) Linearity (%) ALH (µm) BCF (Hz)
Control CC Control CC Control CC Control CC
0 69.1±4.9 72.1±5.1 57.5±4.9 59.2±2.8 2.4±0.3 2.4±0.2 18.5±1.1 18.7±0.7
30 67.0±5.9 69.7±5.2 53.6±4.2 53.6±2.7 2.1±0.1 2.4±0.1 16.4±1.2 17.3±1.0
60 65.9±6.7 69.4±6.3 55.4±5.1 51.7±3.8 2.1±0.1 2.3±0.1 17.2±1.2 17.3±1.1
120 67.3±6.6 64.8±6.8 55.6±3.4 47.9±4.0 2.0±0.1 2.3±0.1 17.5±0.9 16.5±1.3
180 67.6±5.4 68.6±5.9 54.7±3.4 49.5±2.9 1.9±0.1 2.4±0.1 16.8±0.9 16.7±1.1
240 59.8±8.9 67.4±8.3 51.3±4.6 50.8±4.7 1.9±0.2 2.3±0.2 15.5±1.4 16.5±1.8
Spermatozoa progressive motility and coefficients were evaluated by the ISAS system. This experiment was performed at least six times and data are presented as mean±s.e.m. 
ISAS: integrated semen analysis system; AMPK: AMP‑activated kinase; ALH: amplitude of lateral head displacement; BCF: beat cross of flagellum frequency; s.e.m.: standard error of 
the mean; CC: compound C
Supplementary Table 3: Effect of the AMPK inhibition by CC in human 
spermatozoa viability
Time DMSO CC (30 µmol l−1)
5 min 81.7±2.3 81.9±2.3
1 h 79.9±2.9 81.7±3.8
3 h 83.6±3.0 83.4±3.8
24 h 62.9±9.6 56.8±13.0
Spermatozoa viability (%) was measured by flow cytometry using SYBR‑14 and PI as 
probes. This experiment was performed at least five times and data are presented as 
mean±s.e.m. AMPK: AMP‑activated kinase; DMSO: dimethyl sulfoxide; PI: propidium iodide; 
s.e.m.: standard error of the mean; CC: compound C
Supplementary Figure 2: Localization of phospho‑Thr172‑AMPK in human 
spermatozoa bearing an excess of residual cytoplasm (ERC). Active AMPK was 
detected in ERC‑bearing spermatozoa using the anti‑phospho‑Thr172‑AMPK 
antibody and with the secondary antibody Alexa Fluor 488 goat 
anti‑rabbit immunoglobulin G (green) by confocal microscopy (a–f) or 
immunofluorescence (g–i). Sperm nuclei were stained with DAPI (blue). 
Arrows indicate the position of the ERC in each spermatozoon. Images are 










Supplementary Figure 1: Localization of AMPK in human spermatozoa bearing 
an excess of residual cytoplasm (ERC). AMPK was detected in ERC‑bearing 
spermatozoa using an anti‑AMPK antibody against amino acids 251‑550 at 
the C‑terminus of AMPKα subunit and with the secondary antibody Alexa 
Fluor 488 goat anti‑rabbit immunoglobulin G (green) by immunoflourescence 
(a–f) or confocal microscopy (g–i). Sperm nuclei were stained with DAPI (blue). 
Three different patterns (b, e, and h) of AMPK staining in human sperm 
bearing ERC are shown. The arrows indicate the position of the ERC in the 
sperm cell. The images are representative of at least five experiments. Scale 
bars are indicated (5 µm).
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